Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Hookipa Pharma Inc
(NQ:
HOOK
)
2.285
+0.135 (+6.28%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hookipa Pharma Inc
< Previous
1
2
3
4
5
6
7
8
Next >
HOOKIPA to Present a Trial in Progress Poster on its Prostate Cancer Phase 1/2 Clinical Trial at ASCO
April 26, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma to Participate in the Van Lanschot Kempen Life Sciences Conference
April 19, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 14, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Looking Into HOOKIPA Pharma's Return On Capital Employed
March 16, 2023
Via
Benzinga
HOOKIPA Pharma's Earnings Outlook
March 14, 2023
Via
Benzinga
Looking Into HOOKIPA Pharma's Return On Capital Employed
December 23, 2022
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Short Volatility Alert: HOOKIPA Pharma Inc.
October 21, 2022
On Thursday, shares of HOOKIPA Pharma Inc. (NASDAQ: HOOK) experienced volatile short activity. After the activity, the stock price went up +4.96% to $1.27. The overall sentiment for HOOK has been...
Via
Benzinga
HOOKIPA Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
March 15, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
March 13, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 10, 2023
Via
Benzinga
HOOKIPA Pharma to Report Fourth Quarter and Full Year 2022 Financial Results and Provide a Corporate Update on March 15, 2023
March 08, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers
February 13, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 17, 2023
Via
Benzinga
HOOKIPA Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine
January 04, 2023
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA Pharma Appoints Katia Schlienger, M.D., Ph.D., Chief Medical Officer and Malte Peters, M.D., to Board of Directors
December 15, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA to Participate in The JMP Securities Hematology and Oncology Summit
November 30, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
November 25, 2022
Via
Benzinga
Why Advance Auto Parts Shares Are Trading Lower By Around 13%; Here Are 18 Stocks Moving Premarket
November 16, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares rose 55.1% to $0.1578 in pre-market trading after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
HOOKIPA Pharma Announces Third Quarter 2022 Financial Results and Provides a Business Update
November 14, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
Sidoti's November Micro-Cap Virtual Conference
November 08, 2022
Via
ACCESSWIRE
HOOKIPA Pharma to Report Third Quarter 2022 Financial Results and Corporate Updates on November 14, 2022
November 07, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
HOOKIPA to Participate in the Sidoti Micro-Cap Virtual Conference
November 02, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
10 Best Medical Stocks Under $5
October 29, 2022
The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...
Via
Talk Markets
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers
October 20, 2022
HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development
Via
Spotlight Growth
Why Is Indonesia Energy (INDO) Stock Up Today?
October 20, 2022
Indonesia Energy (INDO) stock is climbing higher on Thursday after the company announced the discovery of oil in one of its new wells.
Via
InvestorPlace
Why Is Hookipa (HOOK) Stock Up 26% Today?
October 20, 2022
Hookipa (HOOK) stock is rocketing higher on Thursday after reaching a strategic collaboration and license agreement with Roche (RHHBF).
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 20, 2022
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock increased by 45.5% to $1.76 during Thursday's pre-market session. The market value of their outstanding shares is at $96.2 million.
Via
Benzinga
HOOKIPA announces strategic collaboration and license agreement with Roche to develop novel arenaviral immunotherapy for KRAS-mutated cancers
October 20, 2022
From
HOOKIPA Pharma Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.